The European Medicines Agency (EMA) on Monday said it would review safety data for third- and fourth-generation birth control pills, responding to French concern that these contraceptives may cause dangerous blood clots.
The agency, describing contraceptive pills as carrying only "a very rare risk" of clots, said a special panel would assess whether European guidelines for these drugs should be changed.
Report typos and corrections to corrections@rawstory.com.
For customer support contact support@rawstory.com.
